{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:07:47Z","timestamp":1788782867687,"version":"build-2803163510"},"reference-count":48,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K02394"],"award-info":[{"award-number":["24K02394"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24KJ1195"],"award-info":[{"award-number":["24KJ1195"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K22607"],"award-info":[{"award-number":["25K22607"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008670","name":"Terumo Foundation for Life Sciences and Arts","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100008670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Macropa has formed more stable complexes with 225Ac, although DOTA has been extensively used as a chelator for 225Ac. This study aimed to design and synthesize two novel 225Ac-labeled RGD peptides, [225Ac]Ac-Macropa-c(RGDyK) ([225Ac]1) and [225Ac]Ac-Macropa-[c(RGDyK)]2 ([225Ac]2), and to evaluate their potential for targeted alpha therapy (TAT) of glioblastoma. Further, whether combination therapy with homoarginine (hArg), a modulator of lysosomal function, could further improve therapeutic efficacy was investigated. In Colon-26 cells, [225Ac]2 demonstrated significantly higher cellular uptake and cytotoxicity than [225Ac]1. In Colon-26 tumor-bearing mice, [225Ac]2 exhibited higher tumor accumulation and significant tumor growth inhibition. In GL261 glioblastoma cells, [225Ac]2 showed comparable cellular uptake to that in Colon-26 cells, and combination with hArg in vitro improved its cytotoxicity. However, no significant difference in therapeutic efficacy was observed between the hArg-treated and control groups in the orthotopic GL261 glioblastoma mouse model. The results of this study indicate the potential of 225Ac-labeled RGD peptides incorporating Macropa as a chelator as promising agents for TAT. However, the further optimization of combination strategies and pharmacokinetics is required.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.6c00344","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:36:57Z","timestamp":1785854217000},"page":"4611-4621","source":"Crossref","is-referenced-by-count":0,"title":["Macropa-Based 225Ac-Labeled RGD Peptides\nfor Targeted Alpha Therapy"],"prefix":"10.1021","volume":"23","author":[{"given":"Hiroaki","family":"Echigo","sequence":"first","affiliation":[{"name":"Kanazawa University , , Kakuma-machi , , ,","place":["Kanazawa, Ishikawa, Japan, 920-1192"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Munekane","sequence":"additional","affiliation":[{"name":"Kanazawa University , , Kakuma-machi , , ,","place":["Kanazawa, Ishikawa, Japan, 920-1192"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8141-1212","authenticated-orcid":true,"given":"Takeshi","family":"Fuchigami","sequence":"additional","affiliation":[{"name":"Kanazawa University , , Kakuma-machi , , ,","place":["Kanazawa, Ishikawa, Japan, 920-1192"]},{"name":"Kyoto University , , Nishikyo-ku , ,","place":["Kyoto, Japan, 615-8510"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5071-7574","authenticated-orcid":true,"given":"Kenji","family":"Mishiro","sequence":"additional","affiliation":[{"name":"Kanazawa University , , Kakuma-machi , , ,","place":["Kanazawa, Ishikawa, Japan, 920-1192"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Kikunaga","sequence":"additional","affiliation":[{"name":"Tohoku University , , 6-3 Aoba, Aramaki, Aoba-ku , , ,","place":["Sendai, Miyagi, Japan, 982-0826"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Tsukada","sequence":"additional","affiliation":[{"name":"Tohoku University , , 6-3 Aoba, Aramaki, Aoba-ku , , ,","place":["Sendai, Miyagi, Japan, 982-0826"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Yokokita","sequence":"additional","affiliation":[{"name":"Tohoku University , , 6-3 Aoba, Aramaki, Aoba-ku , , ,","place":["Sendai, Miyagi, Japan, 982-0826"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Shirasaki","sequence":"additional","affiliation":[{"name":"The University of Osaka , , 1-1 Machikaneyama-cho , , ,","place":["Toyonaka, Osaka, Japan, 560-0043"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ichinose","sequence":"additional","affiliation":[{"name":"National Institutes for Quantum Science and Technology (QST) , , 4-9-1 Anagawa , , ,","place":["Inage-ku, Chiba, Japan, 263-8555"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Hinoi","sequence":"additional","affiliation":[{"name":"Gifu Pharmaceutical University , , ,","place":["Gifu, Japan, 501-1196"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Kinuya","sequence":"additional","affiliation":[{"name":"Kanazawa University Hospital, Kanazawa University , , Takara-machi 13-1 , , ,","place":["Kanazawa, Ishikawa, Japan, 920-8641"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-7302","authenticated-orcid":true,"given":"Kazuma","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Kanazawa University , , Kakuma-machi , , ,","place":["Kanazawa, Ishikawa, Japan, 920-1192"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"2026090707075980000_cit1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ccr.2018.12.005","article-title":"Radiotheranostics with\nradiolanthanides: Design, development strategies, and medical applications","volume":"383","author":"Mishiro","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"2026090707075980000_cit2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.nucmedbio.2020.08.004","article-title":"Alpha emitting\nnuclides for targeted therapy","volume":"92","author":"Hatcher-Lamarre","year":"2021","journal-title":"Nucl. Med. Biol."},{"issue":"5","key":"2026090707075980000_cit3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s44211-024-00514-w","article-title":"Recent advances in the development\nof 225Ac- and 211At-labeled radioligands for\nradiotheranostics","volume":"40","author":"Munekane","year":"2024","journal-title":"Anal. Sci."},{"key":"2026090707075980000_cit4","doi-asserted-by":"publisher","first-page":"218173","DOI":"10.1016\/j.ccr.2026.218173","article-title":"Radiotheranostics with High-LET \u03b1-Particle\nand Auger Electron Emitters: A Coordination Chemistry Perspective","volume":"566","author":"Munekane","year":"2026","journal-title":"Coord. Chem. Rev."},{"issue":"9","key":"2026090707075980000_cit5","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1248\/bpb.b25-00195","article-title":"Probes with Tailored\nPharmacokinetics for Radiotheranostics","volume":"48","author":"Munekane","year":"2025","journal-title":"Biol.\nPharm. Bull."},{"issue":"1","key":"2026090707075980000_cit6","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1039\/C3CS60304K","article-title":"Matching chelators to radiometals for radiopharmaceuticals","volume":"43","author":"Price","year":"2014","journal-title":"Chem. Soc. Rev."},{"issue":"4","key":"2026090707075980000_cit7","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s00259-011-2023-6","article-title":"Therapeutic efficacy\nand toxicity of 225Ac-labelled vs. 213Bi-labelled\ntumour-homing peptides in a preclinical mouse model of peritoneal\ncarcinomatosis","volume":"39","author":"Essler","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"9","key":"2026090707075980000_cit8","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.2967\/jnumed.114.138347","article-title":"Efficient\n1-step radiolabeling of monoclonal antibodies to high specific activity\nwith 225Ac for \u03b1-particle radioimmunotherapy of cancer","volume":"55","author":"Maguire","year":"2014","journal-title":"J. Nucl. Med."},{"issue":"46","key":"2026090707075980000_cit9","doi-asserted-by":"publisher","first-page":"14712","DOI":"10.1002\/anie.201709532","article-title":"An Eighteen-Membered Macrocyclic Ligand for Actinium-225\nTargeted Alpha Therapy","volume":"56","author":"Thiele","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"issue":"5","key":"2026090707075980000_cit10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2967\/jnumed.118.219592","article-title":"A Single Dose of 225Ac-RPS-074 Induces a\nComplete Tumor Response in an LNCaP\nXenograft Model","volume":"60","author":"Kelly","year":"2019","journal-title":"J. Nucl. Med."},{"issue":"17","key":"2026090707075980000_cit11","doi-asserted-by":"publisher","first-page":"7203","DOI":"10.7150\/thno.78043","article-title":"Modulating the pharmacokinetic profile of Actinium-225-labeled\nmacropa-derived radioconjugates by dual targeting of PSMA and albumin","volume":"12","author":"Reissig","year":"2022","journal-title":"Theranostics"},{"issue":"4","key":"2026090707075980000_cit12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2967\/jnumed.122.264707","article-title":"225Ac-MACROPATATE: A Novel \u03b1-Particle\nPeptide Receptor Radionuclide Therapy for Neuroendocrine Tumors","volume":"64","author":"King","year":"2023","journal-title":"J. Nucl. Med."},{"issue":"9","key":"2026090707075980000_cit13","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1039\/D3SC06365H","article-title":"Tumor targeted alpha particle therapy\nwith an actinium-225 labelled antibody for carbonic anhydrase IX","volume":"15","author":"Morgan","year":"2024","journal-title":"Chem. Sci."},{"key":"2026090707075980000_cit14","first-page":"2569","article-title":"Conjugation and radiolabelling of\n[225Ac]Ac-macropa-tzPEG3Sq-ch806, a tumour-specific anti-EGFR\nantibody, and preclinical evaluation in a murine glioma model","volume":"63","author":"Christian Wichmann","year":"2022","journal-title":"J. Nucl. Med."},{"issue":"9","key":"2026090707075980000_cit15","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1172\/JCI6869","article-title":"The role\nof \u03b1v integrins during angiogenesis:\ninsights into potential mechanisms of action and clinical development","volume":"103","author":"Eliceiri","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"6","key":"2026090707075980000_cit16","first-page":"1061","article-title":"Radiolabeled \u03b1v\u03b23 integrin antagonists: a new class of tracers for tumor targeting","volume":"40","author":"Haubner","year":"1999","journal-title":"J. Nucl. Med."},{"issue":"3","key":"2026090707075980000_cit17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/ijc.23575","article-title":"\u03b1v\u03b23 Integrin-targeting radionuclide therapy\nand imaging with monomeric\nRGD peptide","volume":"123","author":"Yoshimoto","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"8","key":"2026090707075980000_cit18","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1021\/acs.bioconjchem.5b00186","article-title":"Radiogallium Complex-Conjugated Bifunctional\nPeptides for Detecting Primary Cancer and Bone Metastases Simultaneously","volume":"26","author":"Ogawa","year":"2015","journal-title":"Bioconjug Chem."},{"issue":"6","key":"2026090707075980000_cit19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1248\/cpb.c18-00081","article-title":"Comparison\nof Radioiodine- or Radiobromine-Labeled RGD Peptides between Direct\nand Indirect Labeling Methods","volume":"66","author":"Ogawa","year":"2018","journal-title":"Chem. Pharm.\nBull."},{"issue":"3","key":"2026090707075980000_cit20","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1021\/acsomega.8b03679","article-title":"Radiotheranostics Coupled\nbetween\nan At-211-Labeled RGD Peptide and the Corresponding Radioiodine-Labeled\nRGD Peptide","volume":"4","author":"Ogawa","year":"2019","journal-title":"ACS Omega"},{"issue":"20","key":"2026090707075980000_cit21","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.3390\/molecules26206107","article-title":"Synthesis and Evaluation\nof a Dimeric RGD Peptide as a Preliminary\nStudy for Radiotheranostics with Radiohalogens","volume":"26","author":"Echigo","year":"2021","journal-title":"Molecules"},{"issue":"9","key":"2026090707075980000_cit22","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1021\/acs.molpharmaceut.1c00460","article-title":"68Ga- and 211At-Labeled RGD Peptides for Radiotheranostics\nwith Multiradionuclides","volume":"18","author":"Ogawa","year":"2021","journal-title":"Mol. Pharmaceutics"},{"key":"2026090707075980000_cit23","doi-asserted-by":"publisher","first-page":"116919","DOI":"10.1016\/j.bmc.2022.116919","article-title":"Development\nand evaluation\nof a theranostic probe with RGD peptide introduced platinum complex\nto enable tumor-specific accumulation","volume":"70","author":"Echigo","year":"2022","journal-title":"Bioorg.\nMed. Chem."},{"issue":"24","key":"2026090707075980000_cit24","doi-asserted-by":"publisher","first-page":"16741","DOI":"10.1021\/acs.jmedchem.2c01586","article-title":"RGD Peptide-Conjugated\nDodecaborate with the Ga-DOTA Complex: A Preliminary Study for the\nDevelopment of Theranostic Agents for Boron Neutron Capture Therapy\nand Its Companion Diagnostics","volume":"65","author":"Mishiro","year":"2022","journal-title":"J. Med. Chem."},{"issue":"9","key":"2026090707075980000_cit25","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1039\/D3OB00089C","article-title":"Synthesis and evaluation\nof a deltic guanidinium analogue of a cyclic\nRGD peptide","volume":"21","author":"Mishiro","year":"2023","journal-title":"Org. Biomol. Chem."},{"issue":"2","key":"2026090707075980000_cit26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00259-023-06457-0","article-title":"Development\nof probes for radiotheranostics\nwith albumin binding moiety to increase the therapeutic effects of\nastatine-211 (211At)","volume":"51","author":"Echigo","year":"2024","journal-title":"Eur. J. Nucl.\nMed. Mol. Imaging"},{"issue":"9","key":"2026090707075980000_cit27","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1007\/s00259-024-06695-w","article-title":"Optimizing the pharmacokinetics\nof\nan 211At-labeled RGD peptide with an albumin-binding moiety\nvia the administration of an albumin-binding inhibitor","volume":"51","author":"Echigo","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2026090707075980000_cit28","doi-asserted-by":"publisher","first-page":"109572","DOI":"10.1016\/j.nucmedbio.2025.109572","article-title":"Evaluation of an 211At-labeled\nRGD peptide in an orthotopic glioblastoma model by targeted alpha\ntherapy","volume":"150\u2013151","author":"Echigo","year":"2025","journal-title":"Nucl. Med. Biol."},{"issue":"2","key":"2026090707075980000_cit29","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1007\/s00259-025-07498-3","article-title":"Combination therapy\nof an 211At-labeled RGD peptide and immune checkpoint blockade\nto enhance antitumor efficacy","volume":"53","author":"Echigo","year":"2026","journal-title":"Eur. J. Nucl.\nMed. Mol. Imaging"},{"key":"2026090707075980000_cit30","doi-asserted-by":"publisher","first-page":"108880","DOI":"10.1016\/j.nucmedbio.2024.108880","article-title":"Evaluation of targeting\n\u03b1V\u03b23 in breast cancers using RGD\npeptide-based\nagents","volume":"128\u2013129","author":"Josefsson","year":"2024","journal-title":"Nucl. Med. Biol."},{"issue":"1","key":"2026090707075980000_cit31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/pharmaceutics17010009","article-title":"Long-Term\nTherapeutic Effects of 225Ac-DOTA-E[c(RGDfK)]2 Induced by Radiosensitization via G2\/M Arrest in Pancreatic\nDuctal Adenocarcinoma","volume":"17","author":"Yoshimoto","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"2026090707075980000_cit32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/cas.70222","article-title":"Enhanced Radionuclide\nTherapy via the Conjugation of Pentadecanoic\nAcids With 225Ac- and 177Lu-Labeled RGD Peptides","volume":"117","author":"Yoshimoto","year":"2026","journal-title":"Cancer Sci."},{"key":"2026090707075980000_cit33","doi-asserted-by":"publisher","first-page":"123227","DOI":"10.1016\/j.lfs.2024.123227","article-title":"Glioblastoma\ntherapy: State of the field and future prospects","volume":"359","author":"Khiabani","year":"2024","journal-title":"Life Sci."},{"issue":"23","key":"2026090707075980000_cit34","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of Tumor-Treating Fields Plus Maintenance Temozolomide\nvs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma:\nA Randomized Clinical Trial","volume":"318","author":"Stupp","year":"2017","journal-title":"Jama"},{"issue":"5","key":"2026090707075980000_cit35","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/pharmaceutics14051053","article-title":"Integrin-\u03b1v\u03b23\nas a Therapeutic Target in Glioblastoma: Back to the Future?","volume":"14","author":"Echavidre","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"2026090707075980000_cit36","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1038\/s41467-025-56946-z","article-title":"Lysine-arginine imbalance overcomes therapeutic\ntolerance governed by the transcription factor E3-lysosome axis in\nglioblastoma","volume":"16","author":"Jing","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"2026090707075980000_cit37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/07366290701285108","article-title":"An Improved\nMethod for the Production of Ac-225\/Bi-213 from Th-229 for Targeted\nAlpha Therapy","volume":"25","author":"Zielinska","year":"2007","journal-title":"Solvent Extr. Ion Exch."},{"issue":"7","key":"2026090707075980000_cit38","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1021\/acs.jmedchem.6b00024","article-title":"Purification-Free Method\nfor Preparing Technetium-99m-Labeled Multivalent\nProbes for Enhanced in Vivo Imaging of Saturable Systems","volume":"59","author":"Mizuno","year":"2016","journal-title":"J. Med. Chem."},{"issue":"18","key":"2026090707075980000_cit39","doi-asserted-by":"publisher","first-page":"13429","DOI":"10.1021\/acs.jmedchem.1c00772","article-title":"Radiotheranostics\nUsing a Novel 225Ac-Labeled Radioligand with Improved Pharmacokinetics\nTargeting\nProstate-Specific Membrane Antigen","volume":"64","author":"Iikuni","year":"2021","journal-title":"J. Med.\nChem."},{"issue":"15","key":"2026090707075980000_cit40","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/s41388-021-01745-1","article-title":"CDK8 maintains stemness and tumorigenicity of glioma\nstem cells by regulating the c-MYC pathway","volume":"40","author":"Fukasawa","year":"2021","journal-title":"Oncogene"},{"issue":"21","key":"2026090707075980000_cit41","doi-asserted-by":"publisher","first-page":"16008","DOI":"10.1021\/acs.jmedchem.1c01396","article-title":"Influence of Linker Molecules in Hexavalent RGD Peptides\non Their Multivalent Interactions with Integrin \u03b1v\u03b23","volume":"64","author":"Mizuno","year":"2021","journal-title":"J. Med. Chem."},{"issue":"10","key":"2026090707075980000_cit42","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.7150\/thno.106948","article-title":"EphA2-targeted\nalpha-particle theranostics\nfor enhancing PDAC treatment","volume":"15","author":"Sharma","year":"2025","journal-title":"Theranostics"},{"issue":"11","key":"2026090707075980000_cit43","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1007\/s00259-021-05315-1","article-title":"Preclinical evaluation\nof [225Ac]Ac-DOTA-TATE for treatment of lung neuroendocrine\nneoplasms","volume":"48","author":"Tafreshi","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"5","key":"2026090707075980000_cit44","first-page":"1781","article-title":"Noninvasive imaging of \u03b1v\u03b23 integrin expression using 18F-labeled RGD-containing\nglycopeptide and positron emission tomography","volume":"61","author":"Haubner","year":"2001","journal-title":"Cancer Res."},{"issue":"1","key":"2026090707075980000_cit45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1021\/bc034170n","article-title":"[18F]Galacto-RGD: synthesis,\nradiolabeling, metabolic stability, and radiation dose estimates","volume":"15","author":"Haubner","year":"2004","journal-title":"Bioconjug Chem."},{"issue":"50","key":"2026090707075980000_cit46","doi-asserted-by":"publisher","first-page":"35769","DOI":"10.1074\/jbc.M113.511212","article-title":"Suppression of lysosome function induces autophagy\nvia a feedback down-regulation of MTOR complex 1 (MTORC1) activity","volume":"288","author":"Li","year":"2013","journal-title":"J. Biol. Chem."},{"key":"2026090707075980000_cit47","doi-asserted-by":"publisher","first-page":"774103","DOI":"10.3389\/fimmu.2021.774103","article-title":"mTOR-Mediated Regulation of Immune\nResponses in Cancer and Tumor Microenvironment","volume":"12","author":"Mafi","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"2026090707075980000_cit48","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.2967\/jnumed.120.248062","article-title":"Combination\nStrategies to Improve Targeted Radionuclide Therapy","volume":"61","author":"Chan","year":"2020","journal-title":"J. Nucl. Med."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6c00344","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/9\/4611\/66362537\/acs.molpharmaceut.6c00344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/9\/4611\/66362537\/acs.molpharmaceut.6c00344.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:13:10Z","timestamp":1788779590000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/23\/9\/4611\/5238717\/Macropa-Based-225Ac-Labeled-RGD-Peptides-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,8,3]]},"published-print":{"date-parts":[[2026,9,7]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c00344","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]}}}